Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Yeoh

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Cancers|March 29, 2023
Associations of T-Cell Receptor Repertoire Diversity with L-Asparaginase Allergy in Childhood Acute Lymphoblastic LeukemiaShawn H R Lee, Zhenhua Li, Evelyn H Z Lim, et al.
British Journal of Haematology|July 30, 2013
Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemiaJunli Yan, Nan Jiang, Gaofeng Huang, et al.
Pharmacogenetics and Genomics|February 15, 2013
Nomenclature for alleles of the thiopurine methyltransferase geneMalin L Appell, Jonathan Berg, John Duley, et al.
Clinical Pharmacology and Therapeutics|November 18, 2018
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 UpdateMary V Relling, Matthias Schwab, Michelle Whirl-Carrillo, et al.
British Journal of Haematology|February 23, 2016
New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemiaVincent H J van der Velden, Daphne de Launaij, Jeltje F de Vries, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2020
Successful toxicity reduction during delayed intensification in the non-high-risk arm of Malaysia-Singapore Acute Lymphoblastic Leukaemia 2010 studyBernice L Z Oh, Shawn H R Lee, Koon M Foo, et al.
Stem Cells Translational Medicine|December 18, 2013
Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experienceCecilia Götherström, Magnus Westgren, S W Steven Shaw, et al.
Nature Medicine|September 3, 2024
Fratricide-resistant CD7-CAR T cells in T-ALLBernice L Z Oh, Noriko Shimasaki, Elaine Coustan-Smith, et al.
Asia-Pacific Journal of Clinical Oncology|February 8, 2022
Life-threatening infections during treatment for acute lymphoblastic leukemia on the Malaysia-Singapore 2003 and 2010 clinical trials: A risk prediction modelBernice L Z Oh, Lijia Fan, Shawn H R Lee, et al.
Clinical Pharmacology and Therapeutics|January 31, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 UpdateMaud Maillard, Matthias Schwab, Michelle Whirl-Carrillo, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Cancers|March 29, 2023
Associations of T-Cell Receptor Repertoire Diversity with L-Asparaginase Allergy in Childhood Acute Lymphoblastic LeukemiaShawn H R Lee, Zhenhua Li, Evelyn H Z Lim, et al.
British Journal of Haematology|July 30, 2013
Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemiaJunli Yan, Nan Jiang, Gaofeng Huang, et al.
Pharmacogenetics and Genomics|February 15, 2013
Nomenclature for alleles of the thiopurine methyltransferase geneMalin L Appell, Jonathan Berg, John Duley, et al.
Clinical Pharmacology and Therapeutics|November 18, 2018
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 UpdateMary V Relling, Matthias Schwab, Michelle Whirl-Carrillo, et al.
British Journal of Haematology|February 23, 2016
New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemiaVincent H J van der Velden, Daphne de Launaij, Jeltje F de Vries, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2020
Successful toxicity reduction during delayed intensification in the non-high-risk arm of Malaysia-Singapore Acute Lymphoblastic Leukaemia 2010 studyBernice L Z Oh, Shawn H R Lee, Koon M Foo, et al.
Stem Cells Translational Medicine|December 18, 2013
Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experienceCecilia Götherström, Magnus Westgren, S W Steven Shaw, et al.
Nature Medicine|September 3, 2024
Fratricide-resistant CD7-CAR T cells in T-ALLBernice L Z Oh, Noriko Shimasaki, Elaine Coustan-Smith, et al.
Asia-Pacific Journal of Clinical Oncology|February 8, 2022
Life-threatening infections during treatment for acute lymphoblastic leukemia on the Malaysia-Singapore 2003 and 2010 clinical trials: A risk prediction modelBernice L Z Oh, Lijia Fan, Shawn H R Lee, et al.
Clinical Pharmacology and Therapeutics|January 31, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 UpdateMaud Maillard, Matthias Schwab, Michelle Whirl-Carrillo, et al.
Pageof 9